Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
IDT Australia Limited ( (AU:IDT) ) has issued an announcement.
IDT Australia Limited has announced the planned retirement of its Chief Financial Officer, Mahendran Vasanthakumar, at the end of the month, marking the end of a four-decade career in finance and accounting. This transition is part of a broader restructuring of the company’s finance department, with Malika Perera appointed as the new Head of Finance. Perera brings over two decades of experience in senior financial, commercial, and operational roles across the pharmaceuticals, manufacturing, and distribution sectors. This change is expected to support IDT’s ongoing transformation and strategic initiatives.
More about IDT Australia Limited
IDT Australia Limited is an Australian pharmaceutical manufacturing company based in Boronia, Victoria. The company specializes in the development and production of high potency and high containment pharmaceutical products for both local and international clients. IDT’s facilities are compliant with cGMP standards and are regularly audited by the US FDA and Australian TGA. The company offers comprehensive services for new drug development, scale-up, and commercial active drug manufacture, including various oral and injectable finished drug dose forms.
Average Trading Volume: 211,832
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$28.89M
For detailed information about IDT stock, go to TipRanks’ Stock Analysis page.